NASDAQ:GILD Based on technical analysis, the idea is to go long only if the bottom support level of 60 USD will not be broken. Target prices are: 1. 68USD 2. 80 USD
see charts at www.tradingview.com $DGX Entry 120 Target 1 $125 Target 2 $130 Why DGX? FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use With Covid wave 2 on the rise, this could be a huge player. www.prnewswire.com What is DGX? Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest...
GILEAD SCIENCES, D1: Support zone + 4X Divergence + Nice discount + Breakout of resistance line
see full chart at www.tradingview.com Gild Entry $62 area Target 1 $67 Target 2 $71 stoploss $59 Why this play? Trump used Gild's drug as part of his treatment, if he pulls thru with a full recovery. they will probably start pumping the news about this company and it'll finally have enough momentum to move back to the upside. What is Gild? Gilead Sciences,...
TRUMP PUMP! Gild on high watch with Trump receiving REMDISIVIR treatment and Trump reporting he is feeling better and expected to be discharged and return soon. Which means we could see green market this week. GILD is at my support zone and we have a gap up to fill at $69 If we can hold above $61.62 we could see a move back up to fill that gap. Good opportunity to...
Based on Technical Analysis the best option is to hold and wait the end of the price retracement before going long. Trump has been treated with Gilead Sciences remdesivir.
it maybe a trend reversal for $GILD the stock has good fundamentals ,, and the company was providing COVID-19 medicine for free ,, now they put a price for each patient treatment course nearly 2000$ so it maybe will push the company earnings . it is not a buy or sell recommendation ,, im here to share my ideas .
we're still holding GILD and now it's making another attempt at recovering from the recent drop we need to break the $67 and stay above it for couple of sessions - with strong volume - to flag a proper recovery - the prior attempt for a breakout failed - this time there's some momentum and demand - but still light. we'll see
GILEAD SCIENCES, daily timeframe: Support line + Side of Bollinger bands + Nice discount + Divergence + Hammer
see full chart at www.tradingview.com GSK Entry $39.70 Target 1 $42.45 Target 2 $45.50 Target 3 $48 stoploss 38.70 Why this play? There are 4 general approaches to the Covid vaccine. 1.A "killed" coronavirus that will get recognized as foreign matter in the blood. (Sinovac/Dynavax) 2.Coronavirus proteins themselves, produced industrially in outside cell...
This has pulled right back into the Demand Zone. Looking to start buying here
Hearing chatter down the grape vine about Remdesivir again, watch for the bounce back-up on GILD. This was just trading in the $80 dollar range so keep an eye out for that move on the news.
see full chart at www.tradingview.com AZN Entry $54 area Target $57 stoploss 53 Why this play? Covid Vaccine stocks are hot right now, cases are rising = easy money. What is AZN? AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection,...
Gilead Sciences is one of the largest antiviral producers in the world. Covid 19 pandemic showed that the greatest threat to the existence of humanity comes from Viral infections not wars or other natural disasters. Gilead has hundreds of untested patented antiviral agents that can helps in these kind of situations. Finding the cure for the hardest diseases like...
see full chart at www.tradingview.com AZN Entry $51.68 Target $53 stoploss $50 Why this play? they are really trying to push the Covid wave 2 case, and the market is crash. so if wave 2 really comes, these stocks should pump even further. What is AZN? AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology,...
Gild so far has been ranging. Could def see a retest of $78 this week.